Discussion Compared to usual care , the use of telemedicine was found to improve HbA1c and reduce the risk of moderate hypoglycaemia  in diabetic patients , but without significant difference in BMI
Introduction Hypoglycaemia is a clinical syndrome from various causes , which happens when the blood glucose concentration is too low .
Many studies show that telemedicine intervention can improve glycemic control and has a positive impact on the management of diabetic patients .
The purpose of this study was to evaluate the effect of telemedicine intervention on hypoglycemic event occurrences and results on hemoglobin A1c ( HbA1c ) and body mass index ( BMI ) .
MD‐Logic overnight type 1 diabetes control in home settings: A multicentre, multinational, single blind randomized trial
AIMS To evaluate the safety , efficacy and need for remote monitoring of the MD-Logic closed-loop system during short-term overnight use at home . METHODS Seventy-five patients ( 38 male ; aged 10 - 54 years ; average A1c , 7.8 % ± 0.7 % , 61.8 ± 7.2 mmol/mol ) were enrolled from 3 clinical sites . Patients were r and omly assigned to participate in 2 overnight crossover periods , each including 4 consecutive nights , 1 under closed-loop control and 1 under sensor-augmented pump ( SAP ) therapy in the patient 's home . Both study arms were supervised using a remote-monitoring system in a blinded manner . Primary endpoints were time spent with glucose levels below 70 mg/dL and percentage of nights in which mean overnight glucose levels were within 90 to 140 mg/dL. RESULTS The median [ interquartile range ] percentage of time spent in hypoglycaemia was significantly lower on nights when MD-Logic was used , compared to SAP therapy ( 2.07 [ 0 , 4.78 ] and 2.6 [ 0 , 10.34 ] , respectively ; P = .004 ) and the percentage of individual nights with a mean overnight glucose level in target was significantly greater ( 75 [ 42 , 75 ] and 50 [ 25,75 ] , respectively ; P = .008 ) . The time spent in target range was increased by a median of 28 % ( P = .001 ) , with the same amount of insulin ( 10.69 [ 7.28 , 13.94 ] and 10.41[6.9 , 14.07 ] , respectively ; P = .087 ) . The remote monitoring triggered calls for hypoglycaemia at twice the rate during SAP therapy compared to closed-loop control ( 62 and 29 , respectively ; P = .002 ) . CONCLUSIONS The MD-Logic system demonstrated a safe and efficient profile during overnight use by children , adolescents and adults with type 1 diabetes and , therefore , provides an effective means of mitigating the risk of nocturnal hypoglycaemia
Discussion Compared to usual care , the use of telemedicine was found to improve HbA1c and reduce the risk of moderate hypoglycaemia  in diabetic patients , but without significant difference in BMI
Introduction Hypoglycaemia is a clinical syndrome from various causes , which happens when the blood glucose concentration is too low .
Many studies show that telemedicine intervention can improve glycemic control and has a positive impact on the management of diabetic patients .
The purpose of this study was to evaluate the effect of telemedicine intervention on hypoglycemic event occurrences and results on hemoglobin A1c ( HbA1c ) and body mass index ( BMI ) .